Production (Stage)
REGENXBIO Inc.
RGNX
$10.14
$0.010.10%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -157.69M | -227.10M | -238.81M | -241.08M | -260.15M |
| Total Depreciation and Amortization | 15.99M | 16.22M | 16.53M | 16.94M | 17.32M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 27.56M | 32.23M | 36.92M | 36.61M | 39.31M |
| Change in Net Operating Assets | 30.10M | 5.53M | 3.10M | -3.59M | 10.57M |
| Cash from Operations | -84.04M | -173.13M | -182.26M | -191.12M | -192.94M |
| Capital Expenditure | -2.90M | -2.44M | -2.48M | -3.60M | -5.70M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 137.91M | 105.88M | 99.63M | 89.14M | 146.73M |
| Cash from Investing | 135.01M | 103.45M | 97.15M | 85.55M | 141.03M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.33M | 133.77M | 133.94M | 139.51M | 140.06M |
| Repurchase of Common Stock | -510.00K | -910.00K | -910.00K | -910.00K | -910.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -34.66M | -40.18M | -44.57M | -44.08M | -44.36M |
| Cash from Financing | -33.84M | 92.68M | 88.46M | 94.51M | 94.80M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 17.13M | 23.00M | 3.35M | -11.06M | 42.88M |